Report Detail

Request for Sample of this report

Pharma & Healthcare Global Antibody Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3309760
    • |
  • 12 April, 2019
    • |
  • Global
    • |
  • 136 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Scope of the Report:
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
There is a gap between China antibody manufacturers and Europe/America. In China, about 26% of consumption antibody import from foreign manufactures, such as Hytest, Roche, Thermo Fisher. There are also some local producers, such as Fapon, Genscript, Kitgen, Leadman, MACCURA, Wondfo, etc. Fapon is the leading player in China.
In classification, antibody can be divided into polyclonal antibody and monoclonal antibody. Monoclonal antibody hold the mostly share the China share about 91.12%
In application, antibody downstream is wide and recently antibody has impacted by the hospital, medical research institutions, etc. Hospital holds about 91.21% of whole China antibody consumption in 2016.
The manufacture region is concentrated in Central China, East China and Southwest China, of which East China is the largest region with the share 33.20% in 2016. The sales shares of Southwest China and Central China were 15.12% and 14.56%.
The worldwide market for Antibody is expected to grow at a CAGR of roughly 5.4% over the next five years, will reach 9530 million US$ in 2024, from 7330 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Antibody in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
IgM
IgG
IgA
Other

Market Segment by Applications, can be divided into
Therapeutic
Research
Diagnostic

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody, with price, sales, revenue and global market share of Antibody in 2017 and 2018.
Chapter 3, the Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antibody market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Antibody Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 IgM
      • 1.2.2 IgG
      • 1.2.3 IgA
      • 1.2.4 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Therapeutic
      • 1.3.2 Research
      • 1.3.3 Diagnostic
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Roche
      • 2.1.1 Business Overview
      • 2.1.2 Antibody Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Roche Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Johnson & Johnson
      • 2.2.1 Business Overview
      • 2.2.2 Antibody Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Johnson & Johnson Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Merck
      • 2.3.1 Business Overview
      • 2.3.2 Antibody Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Merck Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Novartis
      • 2.4.1 Business Overview
      • 2.4.2 Antibody Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Novartis Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 AbbVie
      • 2.5.1 Business Overview
      • 2.5.2 Antibody Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 AbbVie Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Amgen
      • 2.6.1 Business Overview
      • 2.6.2 Antibody Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Amgen Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Pfizer
      • 2.7.1 Business Overview
      • 2.7.2 Antibody Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Pfizer Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Bayer
      • 2.8.1 Business Overview
      • 2.8.2 Antibody Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Bayer Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Lilly
      • 2.9.1 Business Overview
      • 2.9.2 Antibody Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Lilly Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Bristol-Myers Squibb
      • 2.10.1 Business Overview
      • 2.10.2 Antibody Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Bristol-Myers Squibb Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 GlaxoSmithKline
      • 2.11.1 Business Overview
      • 2.11.2 Antibody Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 GlaxoSmithKline Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Biogen
      • 2.12.1 Business Overview
      • 2.12.2 Antibody Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Biogen Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 AstraZeneca
      • 2.13.1 Business Overview
      • 2.13.2 Antibody Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 AstraZeneca Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Sanofi
      • 2.14.1 Business Overview
      • 2.14.2 Antibody Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Sanofi Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Alexion Pharmaceuticals
      • 2.15.1 Business Overview
      • 2.15.2 Antibody Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Alexion Pharmaceuticals Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Seattle Genetics
      • 2.16.1 Business Overview
      • 2.16.2 Antibody Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Seattle Genetics Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Antibody Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Antibody Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Antibody Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Antibody Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Antibody Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Antibody Market Analysis by Regions

    • 4.1 Global Antibody Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Antibody Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Antibody Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Antibody Sales and Growth Rate (2014-2019)
    • 4.3 Europe Antibody Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Antibody Sales and Growth Rate (2014-2019)
    • 4.5 South America Antibody Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Antibody Sales and Growth Rate (2014-2019)

    5 North America Antibody by Country

    • 5.1 North America Antibody Sales, Revenue and Market Share by Country
      • 5.1.1 North America Antibody Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Antibody Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Antibody Sales and Growth Rate (2014-2019)
    • 5.3 Canada Antibody Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Antibody Sales and Growth Rate (2014-2019)

    6 Europe Antibody by Country

    • 6.1 Europe Antibody Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Antibody Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Antibody Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Antibody Sales and Growth Rate (2014-2019)
    • 6.3 UK Antibody Sales and Growth Rate (2014-2019)
    • 6.4 France Antibody Sales and Growth Rate (2014-2019)
    • 6.5 Russia Antibody Sales and Growth Rate (2014-2019)
    • 6.6 Italy Antibody Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Antibody by Country

    • 7.1 Asia-Pacific Antibody Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Antibody Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Antibody Revenue and Market Share by Country (2014-2019)
    • 7.2 China Antibody Sales and Growth Rate (2014-2019)
    • 7.3 Japan Antibody Sales and Growth Rate (2014-2019)
    • 7.4 Korea Antibody Sales and Growth Rate (2014-2019)
    • 7.5 India Antibody Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Antibody Sales and Growth Rate (2014-2019)

    8 South America Antibody by Country

    • 8.1 South America Antibody Sales, Revenue and Market Share by Country
      • 8.1.1 South America Antibody Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Antibody Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Antibody Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Antibody Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Antibody Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Antibody by Countries

    • 9.1 Middle East and Africa Antibody Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Antibody Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Antibody Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Antibody Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Antibody Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Antibody Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Antibody Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Antibody Sales and Growth Rate (2014-2019)

    10 Global Antibody Market Segment by Type

    • 10.1 Global Antibody Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Antibody Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Antibody Revenue and Market Share by Type (2014-2019)
    • 10.2 IgM Sales Growth and Price
      • 10.2.1 Global IgM Sales Growth (2014-2019)
      • 10.2.2 Global IgM Price (2014-2019)
    • 10.3 IgG Sales Growth and Price
      • 10.3.1 Global IgG Sales Growth (2014-2019)
      • 10.3.2 Global IgG Price (2014-2019)
    • 10.4 IgA Sales Growth and Price
      • 10.4.1 Global IgA Sales Growth (2014-2019)
      • 10.4.2 Global IgA Price (2014-2019)
    • 10.5 Other Sales Growth and Price
      • 10.5.1 Global Other Sales Growth (2014-2019)
      • 10.5.2 Global Other Price (2014-2019)

    11 Global Antibody Market Segment by Application

    • 11.1 Global Antibody Sales Market Share by Application (2014-2019)
    • 11.2 Therapeutic Sales Growth (2014-2019)
    • 11.3 Research Sales Growth (2014-2019)
    • 11.4 Diagnostic Sales Growth (2014-2019)

    12 Antibody Market Forecast (2019-2024)

    • 12.1 Global Antibody Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Antibody Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Antibody Market Forecast (2019-2024)
      • 12.2.2 Europe Antibody Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Antibody Market Forecast (2019-2024)
      • 12.2.4 South America Antibody Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Antibody Market Forecast (2019-2024)
    • 12.3 Antibody Market Forecast by Type (2019-2024)
      • 12.3.1 Global Antibody Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Antibody Market Share Forecast by Type (2019-2024)
    • 12.4 Antibody Market Forecast by Application (2019-2024)
      • 12.4.1 Global Antibody Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Antibody Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Antibody . Industry analysis & Market Report on Antibody is a syndicated market report, published as Global Antibody Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,690.04
      		4,035.06
      		5,380.08
      		3,239.88
      		4,859.82
      		6,479.76
      		531,361.20
      		797,041.80
      		1,062,722.40
      		293,712.00
      		440,568.00
      		587,424.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo